Skip to search formSkip to main contentSkip to account menu

Amyloidosis

Known as: Amyloidosis NOS, AMYLOID, amyloid diseases 
A group of diseases in which protein builds up in certain organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis… 
National Institutes of Health

Related topics

Related topics

48 relations
2 ML Digoxin 0.25 MG/ML InjectionAcetylcysteineAcetylcysteine 200 MG/ML Inhalant SolutionAmyloid

Narrower (14)

AMYLOIDOSIS, HEREDITARY, CARDIOPATHICAMYLOIDOSIS, SECONDARY GENERALIZEDAmyloid Neuropathies, FamilialAmyloidosis, Primary Cutaneous

Broader (2)

Inborn Errors of MetabolismMetabolic Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation
Despite the importance of the aberrant polymerization of Aβ in the early pathogenic cascade of Alzheimer's disease, little is… 
Highly Cited
2007
Highly Cited
2007
PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
The in vivo imaging probe [11C]-PIB (Pittsburgh Compound B, N-methyl[11C]2-(4'-methylaminophenyl-6-hydroxybenzathiazole) is under… 
Review
2007
Review
2007
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Cerebrovascular dysfunction contributes to the cognitive decline and dementia in Alzheimer's disease (AD), and may precede… 
Review
2005
Review
2005
Structures for amyloid fibrils
Alzheimer's disease and Creutzfeldt–Jakob disease are the best‐known examples of a group of diseases known as the amyloidoses… 
Highly Cited
2004
Highly Cited
2004
Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition
Abundant nonfibrillar oligomeric intermediates are a common feature of amyloid formation, and these oligomers, rather than the… 
Highly Cited
2000
Highly Cited
2000
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Two missense mutations in the gene encoding alpha-synuclein have been linked to rare, early-onset forms of Parkinson's disease… 
Highly Cited
1999
Highly Cited
1999
Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing
Amyloid fibrils are assemblies of misfolded proteins and are associated with pathological conditions such as Alzheimer's disease… 
Highly Cited
1996
Highly Cited
1996
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
Amyloid beta-peptide (A beta) is a major fibrillar component of neuritic plaques in Alzheimer's disease (AD) brains and is… 
Highly Cited
1994
Highly Cited
1994
A role for destabilizing amino acid replacements in light-chain amyloidosis.
Light-chain (L-chain) amyloidosis is characterized by deposition of fibrillar aggregates composed of the N-terminal L-chain… 
Highly Cited
1987
Highly Cited
1987
Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.
Progressive amyloid deposition in senile plaques and cortical blood vessels may play a central role in the pathogenesis of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)